AI-guided treatment for atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests an AI-guided approach to treating atrial fibrillation (AF), a heart rhythm problem. It aims to personalize your treatment plan to better manage symptoms and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You were diagnosed with atrial fibrillation (AF) within the last 6 months.
- You have at least one AF symptom like heart palpitations, dizziness, shortness of breath, or fainting.
- You do not have severe kidney disease (stage 4 or 5) or need dialysis.
- You have no dementia or other condition that affects memory or thinking, and no other serious illness expected to limit life to less than a year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an artificial intelligence (AI) tool to read your heart's electrical activity (ECG) to help doctors better manage your atrial fibrillation (AFib), an irregular heartbeat that can increase stroke risk. By combining the ECG with a heart ultrasound (echocardiogram), the AI aims to improve treatment decisions and outcomes.
This trial uses an artificial intelligence tool to read your heart's electrical signals and check how well your heart is recovering after a procedure to fix an irregular heartbeat called atrial fibrillation. It aims to find early signs of heart failure and guide better care.
This trial is testing a new approach to care for older adults with atrial fibrillation (an irregular heartbeat) who also have other health conditions. It aims to see if a more integrated, team-based care plan helps improve their overall health and quality of life.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
This study tests whether using a smartwatch to track how much time your heart is in AFib each day can help guide treatment. It aims to see if keeping AFib episodes low leads to better outcomes.
This trial tests a mobile education program on a smartphone to help you learn about and manage your atrial fibrillation. If found helpful, it could improve your symptoms and quality of life.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.